We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,756 hedge funds and large institutions have $252B invested in Johnson & Johnson in 2019 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 1,129 increasing their positions, 1,289 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 66

4.93% more ownership

Funds ownership: 68.05%72.98% (+4.9%)

0% less funds holding

Funds holding: 2,7662,756 (-10)

0% less capital invested

Capital invested by funds: $253B → $252B (-$1.14B)

7% less funds holding in top 10

Funds holding in top 10: 690639 (-51)

11% less call options, than puts

Call options by funds: $1.69B | Put options by funds: $1.9B

12% less repeat investments, than reductions

Existing positions increased: 1,129 | Existing positions reduced: 1,289

Holders
2,756
Holders Change
-10
Holders Change %
-0.36%
% of All Funds
59.85%
Holding in Top 10
639
Holding in Top 10 Change
-51
Holding in Top 10 Change %
-7.39%
% of All Funds
13.88%
New
91
Increased
1,129
Reduced
1,289
Closed
66
Calls
$1.69B
Puts
$1.9B
Net Calls
-$208M
Net Calls Change
+$260M
Name Holding Trade Value Shares
Change
Change in
Stake
GCM
1951
Gladius Capital Management
Illinois
$1.29M -$4.89M -35,334 -79%
FPFS
1952
First Personal Financial Services
North Carolina
$1.29M +$35.6K +257 +3%
STMM
1953
South Texas Money Management
Texas
$1.29M -$38.1K -275 -3%
EML
1954
Eos Management LP
New York
$1.29M
BIA
1955
Barry Investment Advisors
Massachusetts
$1.28M +$60.8K +439 +5%
FCA
1956
FLC Capital Advisors
California
$1.28M +$134K +967 +12%
PCG
1957
Private Capital Group
Connecticut
$1.27M -$273K -1,971 -16%
FWM
1958
Focused Wealth Management
New York
$1.27M -$171K -1,234 -12%
DA
1959
Doliver Advisors
Texas
$1.27M +$9.27K +67 +0.7%
GFS
1960
GYL Financial Synergies
Connecticut
$1.27M -$93.2K -673 -7%
CB
1961
Cadence Bank
Mississippi
$1.27M +$179K +1,295 +17%
WCM
1962
Windsor Capital Management
Arizona
$1.26M -$5.4K -39 -0.4%
I2I
1963
Insight 2811 Inc
Illinois
$1.26M -$69.3K -501 -5%
CFN
1964
Cordasco Financial Network
Florida
$1.26M +$14.7K +106 +1%
CFS
1965
CRA Financial Services
New Jersey
$1.26M -$86.5K -625 -6%
MWPCG
1966
Measured Wealth Private Client Group
New Hampshire
$1.25M -$139K -1,001 -10%
SH
1967
Svenska Handelsbanken
Sweden
$1.25M -$388K -2,800 -24%
PG
1968
Proffitt & Goodson
Tennessee
$1.25M -$3.46K -25 -0.3%
BMCM
1969
Bryn Mawr Capital Management
Pennsylvania
$1.25M +$159K +1,146 +15%
MBT
1970
Monroe Bank & Trust
Michigan
$1.25M -$110K -798 -8%
HPWM
1971
Highland Private Wealth Management
Washington
$1.25M +$64.5K +466 +5%
APG
1972
Abacus Planning Group
South Carolina
$1.24M -$69.8K -504 -5%
BMC
1973
Benin Management Corp
Connecticut
$1.24M +$10.5K +76 +0.9%
UA
1974
Unison Advisors
District of Columbia
$1.24M +$7.75K +56 +0.6%
SAM
1975
SignalPoint Asset Management
Missouri
$1.24M -$15.1K -109 -1%

JNJ Hedge Fund Activity: Q2 2019 in Review

2,756 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2019, worth a combined $252B — down 0.45% from $253B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new JNJ positions and 66 closed out — a net gain of 25 holders — while 1,129 added to existing stakes and 1,289 trimmed.

The largest buyer was Phocas Financial Corp, adding an estimated $17.3B. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $719M.

  • 2,756 institutional investors held Johnson & Johnson (JNJ) as of Q2 2019, down from 2,766 in Q1 2019.
  • Funds reported $252B of Johnson & Johnson stock for Q2 2019, down 0.45% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q2 2019 and 66 closed out, a net change of +25 holders.
  • The largest Johnson & Johnson buyer in Q2 2019 was Phocas Financial Corp, an estimated $17.3B added.
  • The largest Johnson & Johnson seller in Q2 2019 was Barrow, Hanley, Mewhinney & Strauss, an estimated $719M sold.

Based on aggregated 13F filings for Q2 2019.